We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$46M
AUM Growth
+$9.19M
Cap. Flow
+$8.51M
Cap. Flow %
18.49%
Top 10 Hldgs %
32.93%
Holding
84
New
19
Increased
17
Reduced
19
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 27.81%
2 Financials 12.76%
3 Technology 5.51%
4 Communication Services 5.04%
5 Consumer Discretionary 2.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
26
Citigroup
C
$230B
$776K 1.69%
18,000
+8,000
+80% +$399K
FIT
27
DELISTED
Fitbit, Inc. Class A common stock
FIT
$752K 1.63%
108,041
-8,359
-7% -$54.3K
MBIO icon
28
Mustang Bio
MBIO
$4.37M
$706K 1.53%
299
-7
-2% -$17.3K
GDX icon
29
VanEck Gold Miners ETF
GDX
$23.8B
$705K 1.53%
18,000
ACRS icon
30
Aclaris Therapeutics
ACRS
$772M
$687K 1.49%
267,466
-206,449
-44% -$462K
IMMU
31
DELISTED
Immunomedics Inc
IMMU
$611K 1.33%
+7,191
New +$364K
XLF icon
32
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
$602K 1.31%
25,000
ERIC icon
33
Ericsson
ERIC
$33.1B
$599K 1.3%
55,000
+10,000
+22% +$110K
XME icon
34
State Street SPDR S&P Metals & Mining ETF
XME
$4.12B
$581K 1.26%
25,000
XOM icon
35
CALL
ExxonMobil
XOM
$638B
$556K 1.21%
16,200
XOM icon
36
ExxonMobil
XOM
$638B
$556K 1.21%
16,200
-98
-0.6% -$4.01K
XOM icon
37
PUT
ExxonMobil
XOM
$638B
$556K 1.21%
16,200
AIMT
38
DELISTED
Aimmune Therapeutics
AIMT
$534K 1.16%
+15,500
New +$330K
VRAY
39
DELISTED
ViewRay, Inc.
VRAY
$499K 1.08%
142,489
-64,652
-31% -$180K
NEM icon
40
Newmont
NEM
$103B
$489K 1.06%
7,700
+349
+5% +$22.8K
TIF
41
DELISTED
Tiffany & Co.
TIF
$475K 1.03%
4,100
-400
-9% -$48.6K
ADMA icon
42
ADMA Biologics
ADMA
$2.03B
$470K 1.02%
196,615
-83,526
-30% -$229K
RST
43
DELISTED
ROSETTA STONE INC
RST
$470K 1.02%
+15,662
New +$406K
EWW icon
44
iShares MSCI Mexico ETF
EWW
$1.98B
$467K 1.01%
14,000
+4,000
+40% +$132K
PCG icon
45
PG&E
PCG
$38.4B
$446K 0.97%
+47,500
New +$440K
EWZ icon
46
iShares MSCI Brazil ETF
EWZ
$9.14B
$443K 0.96%
16,000
+1,000
+7% +$30.7K
ZSAN
47
DELISTED
Zosano Pharma Corporation
ZSAN
$389K 0.85%
6,852
+4,881
+248% +$227K
SAN icon
48
Banco Santander
SAN
$207B
$370K 0.8%
208,696
+88,696
+74% +$191K
BAC icon
49
CALL
Bank of America
BAC
$440B
$361K 0.78%
15,000
BAC icon
50
PUT
Bank of America
BAC
$440B
$361K 0.78%
15,000

Similar funds

Telemetry Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Telemetry Investments held 84 positions worth $46M, up 25% from $36.8M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Telemetry Investments deployed $8.51M of net new capital in Q3 2020, opening 19 new positions and adding to 17 existing holdings. Its largest new stake was Varian Medical Systems, Inc.: 10,300 shares worth $1.77M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Aclaris Therapeutics, an estimated $462K trimmed.

  • Telemetry Investments's largest Q3 2020 buy was Varian Medical Systems, Inc.: 10,300 shares worth $1.77M.
  • Telemetry Investments added most to Willis Towers Watson in Q3 2020, an estimated $1.45M increase.
  • Telemetry Investments's biggest Q3 2020 reduction was Aclaris Therapeutics, cutting an estimated $462K.
  • Telemetry Investments fully exited El Paso Electric Company in Q3 2020, selling an estimated $784K.
  • Telemetry Investments's ten largest holdings make up 33% of its $46M portfolio in Q3 2020.
  • Telemetry Investments opened 19 new positions and closed 11 in Q3 2020.
  • Telemetry Investments's portfolio value rose 25% quarter-over-quarter to $46M.

Based on Telemetry Investments's 13F filing for Q3 2020, filed 16 Nov 2020.